Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ironwood Pharmaceuticals Cash on Hand 2010-2025 | IRWD

Ironwood Pharmaceuticals cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Ironwood Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2024 $89
2023 $92
2022 $657
2021 $621
2020 $364
2019 $178
2018 $174
2017 $221
2016 $305
2015 $439
2014 $248
2013 $198
2012 $168
2011 $164
2010 $251
2009 $122
Ironwood Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $108
2024-12-31 $89
2024-09-30 $88
2024-06-30 $106
2024-03-31 $122
2023-12-31 $92
2023-09-30 $111
2023-06-30 $176
2023-03-31 $742
2022-12-31 $657
2022-09-30 $575
2022-06-30 $506
2022-03-31 $595
2021-12-31 $621
2021-09-30 $576
2021-06-30 $494
2021-03-31 $440
2020-12-31 $364
2020-09-30 $309
2020-06-30 $255
2020-03-31 $232
2019-12-31 $178
2019-09-30 $147
2019-06-30 $107
2019-03-31 $120
2018-12-31 $174
2018-09-30 $161
2018-06-30 $181
2018-03-31 $194
2017-12-31 $221
2017-09-30 $225
2017-06-30 $273
2017-03-31 $297
2016-12-31 $305
2016-09-30 $320
2016-06-30 $325
2016-03-31 $435
2015-12-31 $439
2015-09-30 $462
2015-06-30 $493
2015-03-31 $216
2014-12-31 $248
2014-09-30 $265
2014-06-30 $302
2014-03-31 $332
2013-12-31 $198
2013-09-30 $242
2013-06-30 $301
2013-03-31 $242
2012-12-31 $168
2012-09-30 $193
2012-06-30 $158
2012-03-31 $202
2011-12-31 $164
2011-09-30 $175
2011-06-30 $201
2011-03-31 $221
2010-12-31 $251
2010-09-30 $254
2010-06-30 $272
2010-03-31 $299
2009-12-31 $122
2009-09-30 $99
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.124B $0.351B
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic constipation. Ironwood and AbbVie co-develop & co-commercialize Linzess in all other territories world wide. Linzess is marketed by Allergan for IBS-C in Europe and Canada under the brand name Constella. The company receives royalties on sales of Constella in Europe and Canada from AbbVie. In Japan, it has partnered with Astellas Pharma for the development and commercialization of Linzess and with AstraZeneca in China, Hong Kong & Macau. Linzess received approval for IBS-C indication in Japan for chronic constipation and in China for IBS-C. The company completed the spin-off of its soluble guanylate cyclase segment into a separate, publicly traded company, Cyclerion Therapeutics.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.248B 30.48
Zoetis (ZTS) United States $64.907B 24.22
Daiichi Sankyo, - (DSNKY) Japan $46.828B 24.00
Takeda Pharmaceutical (TAK) Japan $43.656B 8.91
BeOne Medicines - (ONC) Cayman Islands $33.004B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.084B 0.00
Summit Therapeutics (SMMT) United States $19.584B 0.00
Merck (MKKGY) Germany $16.168B 11.85
Shionogi (SGIOY) Japan $14.172B 14.20
Neurocrine Biosciences (NBIX) United States $12.718B 37.94
United Therapeutics (UTHR) United States $12.391B 10.72
Orion OYJ (ORINY) Finland $11.482B 27.67
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.483B 45.76
Grifols, S.A (GRFS) Spain $7.357B 0.00
Corcept Therapeutics (CORT) United States $7.123B 59.44
Ionis Pharmaceuticals (IONS) United States $6.851B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $2.987B 19.65
Crinetics Pharmaceuticals (CRNX) United States $2.677B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.602B 9.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.451B 13.25
NewAmsterdam Pharma (NAMS) Netherlands $2.449B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.294B 0.00
Ocular Therapeutix (OCUL) United States $1.845B 0.00
Endo (NDOI) United States $1.800B 0.00
ARS Pharmaceuticals (SPRY) United States $1.736B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.703B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Dyne Therapeutics (DYN) United States $1.401B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 18.13
Harrow (HROW) United States $1.165B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.017B 0.00
Ardelyx (ARDX) United States $1.014B 0.00
Akebia Therapeutics (AKBA) United States $0.968B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.18
Enliven Therapeutics (ELVN) United States $0.923B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.796B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.607B 0.00
Relay Therapeutics (RLAY) United States $0.603B 0.00
Xencor (XNCR) United States $0.592B 0.00
Organogenesis (ORGO) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.568B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
USANA Health Sciences (USNA) United States $0.547B 11.01
Elite Pharmaceuticals (ELTP) United States $0.546B 0.00
Bioventus (BVS) United States $0.536B 13.58
Oruka Therapeutics (ORKA) United States $0.509B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Savara (SVRA) United States $0.448B 0.00
Aquestive Therapeutics (AQST) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 10.17
AleAnna (ANNA) United States $0.339B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
Altimmune (ALT) United States $0.299B 0.00
Aldeyra Therapeutics (ALDX) United States $0.299B 0.00
Esperion Therapeutics (ESPR) United States $0.281B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.277B 0.00
Nektar Therapeutics (NKTR) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.264B 0.00
Nature's Sunshine Products (NATR) United States $0.259B 16.10
OmniAb (OABI) United States $0.233B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Larimar Therapeutics (LRMR) United States $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Lyell Immunopharma (LYEL) United States $0.175B 0.00
Journey Medical (DERM) United States $0.171B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Liminatus Pharma (LIMN) United States $0.163B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Cardiol Therapeutics (CRDL) Canada $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Achieve Life Sciences (ACHV) Canada $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.087B 19.75
Metagenomi (MGX) United States $0.086B 0.00
Surrozen (SRZN) United States $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Telomir Pharmaceuticals (TELO) United States $0.056B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.33
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
FibroGen (FGEN) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Incannex Healthcare (IXHL) Australia $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 11.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.28
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00